Danielle Bucco


Precision Medicine in HER2+ Breast Cancer Treatment Is Essential

December 21, 2017

Mothaffar Fahed Rimawi, MD, explains the importance of targeting treatments for patients with low levels of HER2 protein based on their genetic mutations, and the possible use of immunotherapy for these patients.

Expert Examines Immunotherapy's Role in Squamous Cell Lung Cancer

November 29, 2017

“Immunotherapy is a new option for patients and is well established,” said George R. Blumenschein, MD. “We are refining how we use it. There will be a number of additional refinements as we have the new data that will be coming forward in the next few months.”

Expert Discusses Treatment Options for Prostate Cancer

November 22, 2017

“Are there ways that we can optimize the cure rates with HIFU? When are people recurring? What are we missing when they recur? What are the true rates of complications? We do not know the answer to most of these questions,” says Jonathan Warner, MD.